Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Opinion in Endocrine and Metabolic Research is Scopus-indexed (Q2, CiteScore 4.4), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Ltd.
Checked against the index lists dated .
ISSN 2451-9650Verify ISSN ↗
Publisher: Elsevier Ltd
Cost to publish: About US$3,320 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 123 / 250 | 51st | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2018–present, best quartile Q2, CiteScore 4.4.
Current Opinion in Endocrine and Metabolic Research is Q2 in Endocrinology, Diabetes and Metabolism (rank 123 of 250), by CiteScore 2025.
Current Opinion in Endocrine and Metabolic Research is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.4, which places it in quartile Q2 at the 51st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.733, quartile Q3, with an H-index of 28.
The publisher lists an article processing charge of about US$3,320 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Current Opinion in Endocrine and Metabolic Research is published by Elsevier Ltd. Its ISSN is 2451-9650.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Current Opinion in Endocrine and Metabolic Research has an h-index of 34 and a 2-year mean of 2.02 citations per paper (OpenAlex). Its Scopus CiteScore is 4.4, quartile Q2. On 2-year citations it ranks #134 of 246 Scopus journals in Endocrinology, Diabetes and Metabolism.
Current Opinion in Endocrine and Metabolic Research published 20 papers in 2025; its busiest recent year was 2020 with 109. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2022–2026), authors are most often from United States (38.2%), United Kingdom (9.3%) and France (7.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.